Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-11-074889
Filing Date
2011-08-09
Accepted
2011-08-09 13:09:32
Documents
9
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q a57978e10vq.htm 10-Q 332154
2 EX-31.1 a57978exv31w1.htm EX-31.1 8160
3 EX-31.2 a57978exv31w2.htm EX-31.2 8438
4 EX-32.1 a57978exv32w1.htm EX-32.1 3957
  Complete submission text file 0000950123-11-074889.txt   1349798

Data Files

Seq Description Document Type Size
5 EX-101 INSTANCE DOCUMENT ands-20110630.xml EX-101.INS 154196
6 EX-101 SCHEMA DOCUMENT ands-20110630.xsd EX-101.SCH 7959
7 EX-101 CALCULATION LINKBASE DOCUMENT ands-20110630_cal.xml EX-101.CAL 22761
8 EX-101 LABELS LINKBASE DOCUMENT ands-20110630_lab.xml EX-101.LAB 87255
9 EX-101 PRESENTATION LINKBASE DOCUMENT ands-20110630_pre.xml EX-101.PRE 52814
Mailing Address 5871 OBERLIN DRIVE, SUITE 200 SAN DIEGO CA 92121
Business Address 5871 OBERLIN DRIVE, SUITE 200 SAN DIEGO CA 92121 8585303600
ANADYS PHARMACEUTICALS INC (Filer) CIK: 0001128495 (see all company filings)

EIN.: 223193172 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50632 | Film No.: 111019852
SIC: 2834 Pharmaceutical Preparations